Insider Selling: Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Sells $263,588.40 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Benjamin Hohl sold 6,018 shares of the stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of $43.80, for a total value of $263,588.40. Following the transaction, the chief financial officer directly owned 51,000 shares of the company’s stock, valued at approximately $2,233,800. This trade represents a 10.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Price Performance

IMRA opened at $17.03 on Thursday. Bitwise MARA Option Income Strategy ETF has a 12 month low of $11.99 and a 12 month high of $54.94. The stock has a market capitalization of $3.24 million, a P/E ratio of 340.60 and a beta of 2.88. The business has a 50 day simple moving average of $16.69 and a 200-day simple moving average of $15.74.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.